NEXON Co., Ltd. has authorized the issuance of 4,180 stock acquisition rights, convertible into 4,180 shares of common stock, as part of its 29th round of equity-based remuneration.
02
The grant is exclusively designated for one external director serving on the company's Audit and Supervisory Committee.
03
The stock options are issued at no cash cost to the recipient and carry a ten-year exercise period beginning April 10, 2026.
04
Eligibility for the options is strictly tied to the recipient's status as a director, with limited provisions for former directors in cases of retirement, resignation, or disability.
05
The issuance includes standard protective clauses for corporate restructuring events, such as mergers or demergers, and prohibits the transfer of options without prior Board approval.
06
Upon exercise, the increase in paid-in capital and capital reserves will be set at 50% of the maximum allowable limit under the Company Accounting Ordinance.
Insights
01
NEXON Co., Ltd. has authorized the issuance of 4,180 stock acquisition rights, convertible into 4,180 shares of common stock, as part of its 29th round of equity-based remuneration.
02
The grant is exclusively designated for one external director serving on the company's Audit and Supervisory Committee.
03
The stock options are issued at no cash cost to the recipient and carry a ten-year exercise period beginning April 10, 2026.
04
Eligibility for the options is strictly tied to the recipient's status as a director, with limited provisions for former directors in cases of retirement, resignation, or disability.
05
The issuance includes standard protective clauses for corporate restructuring events, such as mergers or demergers, and prohibits the transfer of options without prior Board approval.
06
Upon exercise, the increase in paid-in capital and capital reserves will be set at 50% of the maximum allowable limit under the Company Accounting Ordinance.